Cheviot Value Management LLC Buys 2,461 Shares of CVS Health Co. (NYSE:CVS)

Cheviot Value Management LLC grew its stake in CVS Health Co. (NYSE:CVS) by 4.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned 63,435 shares of the pharmacy operator’s stock after acquiring an additional 2,461 shares during the period. CVS Health accounts for approximately 0.7% of Cheviot Value Management LLC’s investment portfolio, making the stock its 28th biggest holding. Cheviot Value Management LLC’s holdings in CVS Health were worth $3,746,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CVS. Gryphon Financial Partners LLC grew its stake in shares of CVS Health by 48.3% in the fourth quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock valued at $654,000 after acquiring an additional 2,653 shares in the last quarter. Congress Wealth Management LLC DE grew its stake in CVS Health by 126.0% during the fourth quarter. Congress Wealth Management LLC DE now owns 6,827 shares of the pharmacy operator’s stock worth $539,000 after buying an additional 3,806 shares in the last quarter. Parallel Advisors LLC grew its stake in CVS Health by 18.2% during the fourth quarter. Parallel Advisors LLC now owns 24,257 shares of the pharmacy operator’s stock worth $1,915,000 after buying an additional 3,732 shares in the last quarter. Mitchell Sinkler & Starr PA grew its stake in CVS Health by 7.0% during the fourth quarter. Mitchell Sinkler & Starr PA now owns 6,229 shares of the pharmacy operator’s stock worth $492,000 after buying an additional 410 shares in the last quarter. Finally, United Services Automobile Association grew its stake in CVS Health by 5.5% during the fourth quarter. United Services Automobile Association now owns 38,141 shares of the pharmacy operator’s stock worth $3,012,000 after buying an additional 1,994 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Robert W. Baird assumed coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective on the stock. Evercore ISI reduced their price objective on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research note on Monday, September 16th. Barclays reduced their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $72.10.

CVS Health Stock Up 0.1 %

CVS Health stock opened at $57.57 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The firm has a 50 day moving average price of $58.28 and a two-hundred day moving average price of $62.32. The firm has a market cap of $72.27 billion, a price-to-earnings ratio of 10.12, a PEG ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same quarter last year, the business earned $2.21 EPS. The company’s revenue was up 2.6% compared to the same quarter last year. Equities analysts predict that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.62%. CVS Health’s payout ratio is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.